VirtualDose fulfils the need for accurate X-ray radiation dose tracking and reporting by providing anatomically correct 3D patient modeling.
Overview of VirtualDose
VirtualDose is a radiation dose tracking and reporting software tool for radiologists, radiological technologists, medical physicists, regulators, manufacturers and researchers who are interested in tracking and managing medical radiation dose. Thanks to the use of a family of 3D anatomically correct patient models, revolutionary GPU-based Monte Carlo simulation, and innovative “Software as a Service” design, VirtualDose permits users to obtain accurate patient-based dosimetry information to greatly improve patient safety. The VirtualDose family now features products for Computed Tomography and Interventional Radiology.
Most Advanced Computational Phantoms
The heart of the VirtualDose system is our family of phantoms: thoroughly-tested, anatomically accurate 3D models of virtual patients. We use third-generation mesh and NURBS-based deformable patient models, including adults of various body sizes, overweight and obese adults, children from newborn through adolescent, and pregnant patients at three gestational stages, to provide accurate radiation dose to a diverse patient population.
Easy to Use, Web-Based
Our easy-to-use radiation dosimetry tool is accessed via the Web. There is no software to install or maintain locally. This way, you are always accessing the most up-to-date version of the software tools. The VirtualDose system can also be accessed using an easy-to-configure API permitting batch processing and integration with local patient databases. In addition, VirtualDose powers the organ dose functionality of several commercial dose monitoring systems world-wide.
Researched and Respected
VirtualDose is the product of many years of research by a globally renowned team of faculty members from Rensselaer Polytechnic Institute (RPI), in collaboration with researchers from the University of Florida (UF). Led by nuclear engineering professor Dr. George Xu, a fellow of the American Association of Medical Physicists, American Nuclear Society, and Health Physics Society, the team founded Virtual Phantoms, Inc. in 2009 and launched an NIH-sponsored commercialization project. VirtualDoseCT became commercially available in 2014, and has quickly become the leading CT organ-dose solution on the market. In 2017, VirtualDoseIR, a new tool for interventional radiology, was launched.
